首页> 外国专利> Hexokinase METHOD noninvasive determination of blood sugar, the hexokinase method of calibrating reagents for noninvasive determination BLOOD SUGAR

Hexokinase METHOD noninvasive determination of blood sugar, the hexokinase method of calibrating reagents for noninvasive determination BLOOD SUGAR

机译:己糖激酶法无创测定血糖,己糖激酶法校正试剂无创测定血糖

摘要

1. The hexokinase method for noninvasive determination of blood sugar, consisting in the fact that the preparation is carried out of the working device for determining blood sugar, wherein a sample and a reagent, wherein the sample used for patient dose saliva and reagent use primary conglomerate monoreaktiva, e.g. Glucose-UV Novo wherein hexokinase additionally contains diaphorase, and saliva and the primary dose conglomerate monoreaktiva placed in a cuvette for mixing them to obtain a solution containing the final conglomerates t monoreaktiva with sugar in the saliva, which increases spectral sensitivity, and reaches the threshold values ​​on the two 190 nm and 340 nm, and established a working device includes a source of light radiation, which is used, for example, a laser diode with a range of wavelengths of light 170- 360 nm, and a filter selector for generating the necessary light beams with wavelengths of 190 nm and 340 nm alternately directed to a quartz cuvette with said solution, wherein the monitor photodetector multisectional its optical tighter STI in directions that arises due to the effect of elastic scattering, that is a different refraction in different directions, and determine the desired value of blood sugar by processing the obtained data protsessorom.2. The method of claim. 1, characterized in that the cuvette is made of an optical transparent material such as quartz, on which there are notches in the form of scratches, in order to more deep and elastic scattering of light rays and create favorable conditions for the effect of elastic scattering in the solution, and the risks location with
机译:1.一种用于非侵入性确定血糖的己糖激酶方法,其特征在于,所述制备是在用于确定血糖的工作装置中进行的,其中样品和试剂,其中用于患者剂量唾液和试剂的样品主要大型企业,例如葡萄糖-UV Novo,其中己糖激酶另外包含黄递酶,并将唾液和主要剂量的砾岩单粒菜置于试管中以将它们混合以获得唾液中含有最终砾岩t单粒菜与糖的溶液,这增加了光谱灵敏度,并达到阈值在两个190 nm和340 nm上分别设置一个值,并建立了一个工作装置,包括一个光辐射源,例如用于波长范围为170-360 nm的激光二极管和一个滤光片选择器用于产生带有所述溶液的,分别指向石英比色皿的波长为190 nm和340 nm的必要光束,其中监视器光电探测器在由于弹性散射的影响而产生的方向上将其光学更紧密的STI分成多个部分,即不同的折射在不同的方向,并通过处理获得的数据protsessorom确定血糖的理想值。2。权利要求的方法。如图1所示,其特征在于,试管由诸如石英之类的光学透明材料制成,其上具有划痕形式的凹口,以使光线更深和更弹性地散射,并为弹性散射的效果创造有利条件。解决方案中的风险位置

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号